ATE160377T1 - Erzeugung von hybrid-genen und proteinen durch rekombination mittels viren - Google Patents
Erzeugung von hybrid-genen und proteinen durch rekombination mittels virenInfo
- Publication number
- ATE160377T1 ATE160377T1 AT90908076T AT90908076T ATE160377T1 AT E160377 T1 ATE160377 T1 AT E160377T1 AT 90908076 T AT90908076 T AT 90908076T AT 90908076 T AT90908076 T AT 90908076T AT E160377 T1 ATE160377 T1 AT E160377T1
- Authority
- AT
- Austria
- Prior art keywords
- viruses
- sequences
- recombination
- proteins
- genes
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 7
- 241000700605 Viruses Species 0.000 title abstract 5
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 230000006798 recombination Effects 0.000 title abstract 3
- 238000005215 recombination Methods 0.000 title abstract 3
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000001228 spectrum Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34005289A | 1989-04-18 | 1989-04-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE160377T1 true ATE160377T1 (de) | 1997-12-15 |
Family
ID=23331664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT90908076T ATE160377T1 (de) | 1989-04-18 | 1990-04-17 | Erzeugung von hybrid-genen und proteinen durch rekombination mittels viren |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0469089B1 (de) |
AT (1) | ATE160377T1 (de) |
DE (1) | DE69031735T2 (de) |
WO (1) | WO1990012880A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9105383D0 (en) * | 1991-03-14 | 1991-05-01 | Immunology Ltd | An immunotherapeutic for cervical cancer |
FR2676071B1 (fr) * | 1991-05-02 | 1994-11-18 | Transgene Sa | Nouveau variant gp160 non-clivable, soluble, de forme hybride. |
DK0587791T3 (da) * | 1991-05-31 | 2004-07-26 | Genentech Inc | Forstærkelse af ekspression ved hjælp af gentargeting i endogene retroviruslignende sekvenser |
US5741492A (en) * | 1996-01-23 | 1998-04-21 | St. Jude Children's Research Hospital | Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses |
US6723558B1 (en) | 1996-01-23 | 2004-04-20 | St. Jude Children's Research Hospital | Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses |
NZ591662A (en) * | 2008-11-21 | 2012-10-26 | Bavarian Nordic As | Vector comprising multiple homologous nucleotide sequences |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986005513A1 (en) * | 1985-03-18 | 1986-09-25 | Gene Labs, Inc. | Hybrid-gene cassette vector |
FR2583429B1 (fr) * | 1985-06-18 | 1989-11-03 | Transgene Sa | Vecteur d'expression de l'interferon u dans les cellules de mammifere, procede pour sa mise en oeuvre et produit obtenu et composition pharmaceutique contenant l'interferon u |
NZ217645A (en) * | 1985-09-25 | 1991-11-26 | Oncogen | Recombinant viruses expressing lav/htlv-iii related epitopes and vaccine formulations |
-
1990
- 1990-04-17 EP EP90908076A patent/EP0469089B1/de not_active Expired - Lifetime
- 1990-04-17 WO PCT/US1990/002060 patent/WO1990012880A1/en active IP Right Grant
- 1990-04-17 AT AT90908076T patent/ATE160377T1/de active
- 1990-04-17 DE DE69031735T patent/DE69031735T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0469089A1 (de) | 1992-02-05 |
DE69031735T2 (de) | 1998-03-12 |
WO1990012880A1 (en) | 1990-11-01 |
DE69031735D1 (de) | 1998-01-02 |
EP0469089B1 (de) | 1997-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE97164T1 (de) | Rekombinantes vaccinia-virus mva. | |
JP7326157B2 (ja) | Hbvワクチン | |
AR003125A1 (es) | Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la | |
AR058249A2 (es) | Una molecula aislada de polinucleotido que comprende una secuencia de adn que codifica una molecula infecciosa de arn que codifica un virus prrs norteamericano, celula transfectada y vacuna | |
BR9205771A (pt) | Vetor de vírus recombinantes e processo para a fabricaçao do mesmo | |
SG60387G (en) | Recombinant dna, hosts transformed with it and polypeptides; compositions and means containing the polypeptides; dna sequences | |
MY103182A (en) | Vaccines against acquired immune deficiency syndrome. | |
EP0278940A3 (de) | Hepatitis-B-Virus-Oberflächenantigene und sie enthaltende hybride Antigene | |
ES2099066T3 (es) | Antigenos a partir de adn sintetico derivado del virus de la inmunodeficiencia humana (hiv-1). | |
ES2191929T3 (es) | Respuestas inmunologicas contra los antigenos pvh estimuladas por composiciones que comprenden un antigeno pvh y una proteina de estres o un vector de expresion capaz de expresar dichas proteinas. | |
DK0835133T3 (da) | Rekombinant koppevirus-rabies-præparater og kombinationspræparater samt anvendelser deraf | |
CN101969996A (zh) | 多价疫苗 | |
DE69942810D1 (de) | Modifizierter Hitzeschockprotein-Antigenpeptid-Komplex | |
ATE160377T1 (de) | Erzeugung von hybrid-genen und proteinen durch rekombination mittels viren | |
DK1119630T3 (da) | Nukleinsyrekonstruktioner til genetisk immunisering | |
ES8304204A1 (es) | Un metodo de producir un polipeptido que presenta la especialidad de los antigenos virales de la glosopeda (fmo). | |
RU2004108115A (ru) | Рекомбинантные антитела и композиции, а также способы их создания и использования | |
ES529225A0 (es) | Un procedimiento para preparar un organismo unicelular que tiene una secuencia de adn que codifica un plipeptid0 que tiene un determinante inmunorreactivo u antigeno de una glicoproteina de virus de herpes simplex. | |
ATE166390T1 (de) | Anti-katze immundefiziensvirus (fiv) impfstoffe | |
DK1432439T3 (da) | Middel til forbedring af immunsvaret | |
DK498387A (da) | Virus-dna-sekvens | |
ATE136933T1 (de) | Rekombinante hbsag hybridpartikel, die morphologische eigenschaften von hbsag-antigen haben und eine immunogene sequenz enthalten, die neutralisierende antikörper gegen hiv induziert oder die von diesen antikörpern erkannt ist, nukleotide sequenzen, die diese partikel codieren und sie enthaltende impfstoffe | |
Ishii et al. | A novel immunogen selectively eliciting CD8+ T cells but not CD4+ T cells targeting immunodeficiency virus antigens | |
CU22666A1 (es) | Procedimiento para la expresión de genes de los virus del dengue en la levadura pichia pastoris, adns recombinantes y microorganismos transformados | |
ES2367245T8 (es) | Virus recombinante que expresa adn foráneo que codifica cd80 felino, cd28 felino, ctla-4felino o cd86 felino y usos del mismo. |